State Reform Dominates Boston Health Care Market Dynamics
Originally published by the Center for Studying Health System Change
Published: September 2010
Updated: April 5, 2026
HSC Community Report No. 1, September 2010. By Ha T. Tu, Marisa K. Dowling, Laurie E. Felland, Paul B. Ginsburg, and Ralph C. Mayrell. Drawing on more than 50 interviews conducted across the Boston metropolitan area in March 2010, this report documents how Massachusetts' groundbreaking 2006 health reform law was reshaping insurance markets, hospital competition, and the broader cost landscape in one of the nation's most prominent medical hubs.
A Bellwether for National Health Reform
By 2010, Massachusetts had established itself as the leading test case for what comprehensive health reform could look like at a national scale. The state's 2006 law—signed by then-Governor Mitt Romney—introduced an individual mandate, expanded Medicaid eligibility, created a health insurance exchange (the Connector), and merged the small-group and individual insurance markets. These structural changes preceded the federal Affordable Care Act by four years, making Boston an essential laboratory for policymakers across the country.
The coverage gains were striking. Massachusetts' uninsured rate fell from 8.2 percent in 2006 to just 2.7 percent by 2009—a drop that far outpaced any other state. Public support for the reform law stayed broadly positive even as costs became a growing source of friction, particularly among smaller employers who bore the sharpest premium increases. The political consensus held, but cracks were forming around affordability.
The Merged Insurance Market and Its Unintended Consequences
One of the more consequential—and less anticipated—features of the reform was the merger of the small-group and individual insurance markets into a single risk pool. Proponents had argued this would stabilize premiums for individuals who previously faced volatile pricing. In practice, the merger shifted costs onto small employers. Because the individual market had historically carried higher per-person claims, folding those enrollees into the small-group pool drove premiums upward for businesses that had previously enjoyed somewhat lower rates.
Small employers were vocal in their frustration. Many reported premium increases that exceeded what they had budgeted, and the political fallout was significant. Trade groups representing small businesses pressed state officials for relief, arguing that the merged market was penalizing firms that had been responsibly covering their workers all along.
The individual mandate itself was widely viewed as too weak to fully address adverse selection. The annual penalty for remaining uninsured—roughly $1,068 at the time—amounted to only about half the cost of the cheapest available health plan. That gap created a financial incentive for so-called "jumpers": people who stayed uninsured during healthy periods and purchased coverage only when they anticipated needing expensive care. This pattern undermined the risk pool and contributed to upward pressure on premiums throughout the merged market.
The Premium Rollback Battle
Tensions over small-group premiums came to a head when Governor Deval Patrick's administration took the unusual step of rejecting proposed premium increases for small-group plans. The state Division of Insurance refused to approve rate filings it considered excessive—a move that prompted several health plans to file legal challenges. The standoff was eventually resolved through settlement agreements that capped increases at around eight percent, well below what insurers had originally sought.
The episode highlighted a fundamental tension in the Massachusetts model. The state had expanded access dramatically but had not yet tackled the underlying cost structure that made coverage expensive. Rate regulation was a blunt instrument—it provided short-term relief but left unresolved the provider payment dynamics and market concentration that were the real engines of premium growth.
Three large nonprofit health plans dominated the Boston market: Blue Cross Blue Shield of Massachusetts held roughly half of all enrollment, followed by Harvard Pilgrim Health Care at about 20 percent and Tufts Health Plan at around 15 percent. These three carriers wielded considerable influence, but they also operated under intense scrutiny from regulators and the public. Their ability to manage costs was constrained by the bargaining power of the region's hospital systems.
Academic Medical Centers as the Primary Cost Drivers
Boston's health care market has long been defined by its concentration of prestigious academic medical centers (AMCs). Institutions like Massachusetts General Hospital, Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, and several others anchor a medical economy that attracts patients from across the region and beyond. These hospitals command the highest reimbursement rates from insurers—and their leverage in negotiations was a central theme of the HSC report.
Partners HealthCare, the parent system of Mass General and Brigham and Women's, occupied a singular position. As the largest hospital network in the state, Partners was widely described as the "rate setter"—the system whose negotiated prices established the upper boundary for what insurers would pay. Other hospital systems benchmarked their own negotiations against Partners' rates, creating a ratchet effect that pushed prices higher across the board.
A landmark report from the Massachusetts Attorney General's office quantified this dynamic. It found that approximately 75 percent of the growth in health care spending was attributable to increases in provider prices rather than changes in how much care people used. Only about 25 percent of the spending trend could be traced to rising utilization. The implication was clear: cost containment in Massachusetts would require directly confronting the pricing power of its most prominent hospital systems.
Suburban Expansion and Competitive Pressures
The AMCs were not content to rely solely on their urban campuses. By 2010, several major systems—Partners chief among them—were aggressively expanding into suburban communities through satellite clinics, outpatient centers, and physician practice acquisitions. This outward push served multiple strategic purposes: it captured referral streams closer to where patients lived, extended brand reach into affluent suburban markets, and made it even harder for insurers to build networks that excluded high-cost academic providers.
For community hospitals already operating on thinner margins, the suburban expansion of AMCs represented a serious competitive threat. Patients who might have been treated at a local community hospital were increasingly being funneled into AMC-affiliated networks, often at higher prices. Several community hospitals reported losing key service lines—orthopedics, cardiology, and other profitable specialties—to nearby AMC satellite facilities. The result was a gradual hollowing out of the community hospital business model, raising concerns about long-term access for residents who depended on these institutions.
Shifts in the Safety Net
The coverage expansion brought mixed results for safety-net providers. Community health centers (CHCs) were among the clearest beneficiaries of reform. As hundreds of thousands of previously uninsured residents gained coverage, CHCs saw a significant shift in their payer mix—fewer uncompensated care visits and more encounters covered by Medicaid or subsidized plans through the Connector. This translated into improved financial stability for many CHCs and allowed some to expand services.
Safety-net hospitals faced a more complicated picture. Institutions like Boston Medical Center, which had historically served a disproportionate share of uninsured patients, did benefit from the coverage expansion. However, Medicaid reimbursement rates in Massachusetts remained well below commercial rates, and the newly insured population often carried plans with low payment levels. At the same time, the supplemental funding mechanisms that had supported safety-net hospitals during the era of high uninsurance were being scaled back. These hospitals found themselves caught between a declining uncompensated care pool and inadequate reimbursement from the coverage programs that replaced it.
Emerging Cost-Containment Strategies
With cost pressures mounting, policymakers and insurers were exploring several strategies to bend the spending curve. Global payment—a model in which provider organizations receive a fixed budget for all of a patient's care rather than being paid per service—was gaining traction in policy discussions. Blue Cross Blue Shield of Massachusetts had launched its Alternative Quality Contract, an early large-scale experiment in global budgeting that would later draw national attention. Proponents argued that global payment could shift incentives away from volume and toward efficiency, though skeptics worried about the risks of underfunding and reduced access.
Consumer-directed health plans (CDHPs)—typically high-deductible plans paired with health savings accounts—were growing in enrollment, though from a small base. Employers saw these plans as a way to share costs with workers and encourage more careful use of services. The adoption rate in Boston lagged behind national trends, partly because the market's strong union presence and tradition of comprehensive benefits made high-deductible plans a harder sell.
Tiered and limited network products were also developing. Under these designs, enrollees paid lower cost-sharing when they used providers classified in a lower-cost tier—typically community hospitals and independent physicians—and higher cost-sharing when they chose AMCs or other expensive providers. The logic was straightforward: give consumers a financial reason to seek care at less costly facilities. But the practical challenges were considerable. In a market where AMCs held such prestige and brand loyalty, convincing patients to choose a lower-tier provider required more than a modest copayment differential.
Policy Implications and the Road Ahead
Boston's experience through 2010 offered a sobering preview for the rest of the country. Massachusetts had demonstrated that near-universal coverage was achievable through a combination of mandates, subsidies, and market restructuring. But it had also shown that expanding access without simultaneously addressing cost drivers was a recipe for escalating fiscal strain. The state was spending more on health care than ever, and the political fights over premiums were intensifying.
The concentration of market power among a handful of hospital systems—especially Partners HealthCare—posed a structural challenge that no single policy lever could easily resolve. Rate regulation, as the premium rollback episode demonstrated, could provide temporary relief but did not change the underlying negotiating dynamics. Global payment held theoretical promise, but its real-world implementation was just beginning and would take years to evaluate.
For community hospitals and safety-net providers, the market trajectory was particularly worrying. The suburban expansion of AMCs threatened to erode the patient base that community institutions depended on, while the financial benefits of coverage expansion were partially offset by low reimbursement rates and shrinking supplemental funding.
The merged insurance market, while achieving its goal of stabilizing individual premiums, had created new friction points for small employers—a constituency with outsized political voice. And the weakness of the individual mandate was allowing adverse selection patterns that undermined the very risk pooling the reform depended on.
These lessons from Boston's post-reform landscape would prove directly relevant as the federal government moved to implement the Affordable Care Act. The Massachusetts experiment showed that coverage expansion was the easier half of the equation. The harder work—restructuring provider payment, moderating hospital market power, and building sustainable cost controls—was still ahead.